Elsevier

Brain Research

Volume 618, Issue 2, 6 August 1993, Pages 227-237
Brain Research

Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an ω3 site ligand

https://doi.org/10.1016/0006-8993(93)91270-3Get rights and content

Abstract

Previous investigations have indicated that the measurement of ω3 (peripheral-type benzodiazepine) binding site densities could be of widespread applicability in the localization and quantification of neural tissue damage in the central nervous system. In the first step of the present study, the suitability of this approach for the assessment of soman-induced brain damage was validated. Autoradiographic study revealed marked increases of ω3 site densities in several brain areas of convulsing rats 2 days after soman challenge. These increases were well-correlated with the pattern and the amplitude of neuropathological alterations due to soman and closely related to both glial reaction and macrophage invasion of the lesioned tissues. We then used this marker to assess, in mouse hippocampus, the neuroprotective activity against soman-induced brain damage of NBQX and TCP which are respective antagonists of non-NMDA and NMDA glutamatergic receptors. Injection of NBQX at 20 or 40 mg/kg 5 min prior to soman totally prevented the neuronal damage. Comparatively, TCP had neuroprotective efficacy when administered at 1 mg/kg 5 min prior to soman followed by a reinjection 1 h after. These results demonstrate that both NBQX and TCP afford a satisfactory neuroprotection against soman-induced brain damage. Since it is known that the neuropathology due to soman is closely seizure-related, the neuroprotective activities of NBQX and TCP are discussed in relation with the respective roles of non-NMDA and NMDA receptors in the onset and maintenance of soman-induced seizures.

References (46)

  • LeeW.L. et al.

    Involvement of non-NMDA receptors in picrotoxin-induced epileptiform activity in the hippocampus

    Neurosci. Lett.

    (1989)
  • LowryO.H. et al.

    Protein measurement with the Folin phenol reagent

    J. Biol. Chem.

    (1951)
  • MeldrumB. et al.

    Excitatory amino acid neurotoxicity and neurodegenerative disease

    Trends Pharmacol. SSci.

    (1990)
  • NeumanR.S. et al.

    Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the hippocampus in vitro

    Neurosci. Lett.

    (1988)
  • PazdernikT.L. et al.

    Changes in local cerebral glucose utilization induced by convulsants

    Neuroscience

    (1985)
  • ReltonJ.K. et al.

    Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

    Brain Res. Bull.

    (1992)
  • SloviterR.S. et al.

    ‘Epileptic’ brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine

    Brain Res. Bull.

    (1985)
  • SmithS.E. et al.

    The non-N-methyl-d-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

    Eur. J. Pharmacol.

    (1991)
  • SparenborgS. et al.

    Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman

    Neuropharmacology

    (1992)
  • BenavidesD. et al.

    The quantification of brain lesions with an ω3 ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration

    Brain Res.

    (1990)
  • BenavidesJ. et al.

    Imaging of human brain lesions with an ω3 site radioligand

    Ann. Neurol.

    (1988)
  • BenavidesJ. et al.

    Labelling of ‘peripheral type’ benzodiazepine binding sites in the rat brain. Kinetic studies and autoradiographic localization

    J. Neurochem.

    (1983)
  • BlanchetG. et al.

    Anticonvulsant effect of N-[1-(2-Thienyl)cyclohexyl]-piperidine (TCP) in soman poisoning

  • Cited by (64)

    • Cerebral blood flow and oxygenation in rat brain after soman exposure

      2021, Toxicology Letters
      Citation Excerpt :

      Treatment protocols involve attenuation of peripheral symptoms and prevention of convulsive seizures (Barker et al., 2020; Sidell, 1998). However, current treatments are unable to provide neuroprotection unless seizures are quickly terminated (Baille et al., 2005; Lallement et al., 1993). It is accepted that exposure to NAs causes neurological damage (Philippens et al., 1992).

    • Assessment of brain oxygenation imbalance following soman exposure in rats

      2018, NeuroToxicology
      Citation Excerpt :

      In other studies, either through innate tolerance or anti-seizure medication, in the absence of convulsive seizures, no neurological degeneration was observed (Apland et al., 2010; Baille et al., 2005; Guo et al., 2015; Lallement et al., 1993; McDonough et al., 1987). When convulsive seizures were terminated within 20 min, minimal neuronal loss was seen (Baille et al., 2005; Lallement et al., 1993), indicating the presence and duration of seizures to be a critical factor in soman related neurological damage. Seizures induced by soman (Shih and McDonough, 1997) cause neurological damage through excitotoxicity (Fujikawa et al., 2000; Lallement et al., 1993; Olney et al., 1974).

    • General Overview

      2014, Best Synthetic Methods: Organophosphorus (V) Chemistry
    • Cyclooxygenase-2 contributes to VX-induced cell death in cultured cortical neurons

      2012, Toxicology Letters
      Citation Excerpt :

      When this enzyme is inhibited, there is an accumulation of the neurotransmitter in the synaptic cleft resulting, for doses that are sufficient, in the progression of toxic signs including hypersecretions, tremors, convulsions, respiratory distress and ultimately death (Weinbroum, 2005). Glutamate receptors are thought to participate in the propagation and maintenance of OP-induced seizures and to play a major role in mediating the CNS neurotoxicity of OP nerve agent after seizures (e.g. Lallement et al., 1993; Solberg and Belkin, 1997). It has been suggested that the glutamate released by nerve agent exposure plays a role in mediating neuronal death following OP-induced CNS intoxication (e.g. McDonough and Shih, 1997; Lallement et al., 1992; Solberg and Belkin, 1997).

    • Nerve agent intoxication: Recent neuropathophysiological findings and subsequent impact on medical management prospects

      2011, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Indeed, from post-soman day 4 to post-soman day 22, the number of monocytes and granulocytes in the blood circulation had considerably increased (Collombet et al., 2005a). Phagocytic events involving activated monocytes (invading macrophages) and granulocytes are required in damaged brain regions to remove accumulated cell debris, as suggested by the macrophage invasion already observed in wounded brain regions 1, 2 and 7 days after soman exposure (Baille et al., 2005; Lallement et al., 1993). The extensive need for activated monocytes and granulocytes in the brain could contribute to further cell quantity increase in blood (Fig. 2).

    View all citing articles on Scopus
    View full text